USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	056405/0198			Pages:	20
		Recorded:	06/01/2021
Attorney Dkt #:	111005 ASSIGNMENT ONCOC4
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 13

Patent #:	9427413	Issue Dt:	08/30/2016	Application #:	13513659	Filing Dt:	07/02/2012
Publication #:	US20120264697	Pub Dt:	10/18/2012
Title:	USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

Patent #:	9623070	Issue Dt:	04/18/2017	Application #:	15234195	Filing Dt:	08/11/2016
Publication #:	US20170035832	Pub Dt:	02/09/2017
Title:	USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

Patent #:	9877998	Issue Dt:	01/30/2018	Application #:	15448737	Filing Dt:	03/03/2017
Publication #:	US20170239315	Pub Dt:	08/24/2017
Title:	USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

Patent #:	NONE	Issue Dt:		Application #:	15839643	Filing Dt:	12/12/2017
Publication #:	US20180177841	Pub Dt:	06/28/2018
Title:	USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

Patent #:	10618960	Issue Dt:	04/14/2020	Application #:	16062350	Filing Dt:	06/14/2018
Publication #:	US20190127468	Pub Dt:	05/02/2019
Title:	Chimeric and Humanized Anti-Human CTLA4 Monoclonal Antibodies and Uses Thereof

Patent #:	NONE	Issue Dt:		Application #:	16294615	Filing Dt:	03/06/2019
Publication #:	US20190255140	Pub Dt:	08/22/2019
Title:	USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

Patent #:	11261233	Issue Dt:	03/01/2022	Application #:	16333888	Filing Dt:	03/15/2019
Publication #:	US20190263889	Pub Dt:	08/29/2019
Title:	CD80 and CD86 Binding Protein Compositions and Uses Thereof

Patent #:	NONE	Issue Dt:		Application #:	16748455	Filing Dt:	01/21/2020
Publication #:	US20200147167	Pub Dt:	05/14/2020
Title:	USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

Patent #:	11629188	Issue Dt:	04/18/2023	Application #:	16803972	Filing Dt:	02/27/2020
Publication #:	US20200283526	Pub Dt:	09/10/2020
Title:	Chimeric and Humanized Anti-Human CTLA4 Monoclonal Antibodies and Uses Thereof

Patent #:	NONE	Issue Dt:		Application #:	16967065	Filing Dt:	08/03/2020
Publication #:	US20210047410	Pub Dt:	02/18/2021
Title:	METHODS OF SELECTING AND DESIGNING SAFER AND MORE EFFECTIVE ANTI-CTLA-4 ANTIBODIES FOR CANCER THERAPY

Patent #:	NONE	Issue Dt:		Application #:	16967079	Filing Dt:	08/03/2020
Publication #:	US20210040212	Pub Dt:	02/11/2021
Title:	MUTANT ANTI-CTLA-4 ANTIBODIES WITH IMPROVED IMMUNOTHERAPEUTIC EFFECT BUT ATTENUATED ADVERSE EFFECTS

Patent #:	NONE	Issue Dt:		Application #:	17055248	Filing Dt:	06/08/2021
Publication #:	US20210214458	Pub Dt:	07/15/2021
Title:	ANTI-CD24 COMPOSITIONS AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17069300	Filing Dt:	10/13/2020
Publication #:	US20210161991	Pub Dt:	06/03/2021
Title:	USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS

Assignor

Exec Dt:

12/18/2020

Assignee

9640 MEDICAL CENTER DRIVE

ROCKVILLE, MARYLAND 20850

Correspondence name and address
	POLSINELLI PC
	1201 WEST PEACHTREE STREET, NW, SUITE 1100
	ATLANTA, GA 30309

Search Results as of: 06/14/2024 10:15 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6